Mayo Clinic Graduate School of Biomedical Sciences, Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic Graduate School of Biomedical Sciences, Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota; Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota.
Heart Rhythm. 2018 Apr;15(4):555-561. doi: 10.1016/j.hrthm.2017.11.032. Epub 2017 Dec 2.
Mutations in the KCNQ1-encoded Kv7.1 potassium channel cause long QT syndrome (LQTS) type 1 (LQT1). It has been suggested that ∼10%-20% of rare LQTS case-derived variants in the literature may have been published erroneously as LQT1-causative mutations and may be "false positives."
The purpose of this study was to determine which previously published KCNQ1 case variants are likely false positives.
A list of all published, case-derived KCNQ1 missense variants (MVs) was compiled. The occurrence of each MV within the Genome Aggregation Database (gnomAD) was assessed. Eight in silico tools were used to predict each variant's pathogenicity. Case-derived variants that were either (1) too frequently found in gnomAD or (2) absent in gnomAD but predicted to be pathogenic by ≤2 tools were considered potential false positives. Three of these variants were characterized functionally using whole-cell patch clamp technique.
Overall, there were 244 KCNQ1 case-derived MVs. Of these, 29 (12%) were seen in ≥10 individuals in gnomAD and are demotable. However, 157 of 244 MVs (64%) were absent in gnomAD. Of these, 7 (4%) were predicted to be pathogenic by ≤2 tools, 3 of which we characterized functionally. There was no significant difference in current density between heterozygous KCNQ1-F127L, -P477L, or -L619M variant-containing channels compared to KCNQ1-WT.
This study offers preliminary evidence for the demotion of 32 (13%) previously published LQT1 MVs. Of these, 29 were demoted because of their frequent sighting in gnomAD. Additionally, in silico analysis and in vitro functional studies have facilitated the demotion of 3 ultra-rare MVs (F127L, P477L, L619M).
KCNQ1 编码的 Kv7.1 钾通道突变导致长 QT 综合征 (LQTS) 1 型 (LQT1)。有人提出,文献中约有 10%-20%的罕见 LQTS 病例衍生变异可能被错误地发表为 LQT1 致病突变,可能是“假阳性”。
本研究旨在确定哪些先前发表的 KCNQ1 病例变异可能是假阳性。
编制了一份所有已发表的病例衍生 KCNQ1 错义变异 (MV) 的清单。评估每个 MV 在基因组聚集数据库 (gnomAD) 中的出现情况。使用 8 种计算工具预测每个变体的致病性。被认为是潜在假阳性的病例衍生变异要么 (1) 在 gnomAD 中过于频繁地发现,要么 (2) 在 gnomAD 中不存在,但被 ≤2 种工具预测为致病性。对其中的 3 种变体进行了全细胞贴附式膜片钳技术的功能特征描述。
总体而言,有 244 个 KCNQ1 病例衍生 MV。其中,29 个 (12%) 在 gnomAD 中至少有 10 个人存在,是可排除的。然而,244 个 MV 中有 157 个 (64%) 在 gnomAD 中不存在。其中,7 个 (4%) 被 ≤2 种工具预测为致病性,我们对其中的 3 个进行了功能特征描述。与 KCNQ1-WT 相比,杂合 KCNQ1-F127L、-P477L 或 -L619M 变异通道的电流密度没有显著差异。
本研究初步证明了 32 个 (13%) 先前发表的 LQT1 MV 的降级。其中,29 个因为在 gnomAD 中频繁出现而被降级。此外,计算分析和体外功能研究促进了 3 个超罕见 MV (F127L、P477L、L619M) 的降级。